HEADER SIGNALING PROTEIN/AGONIST 20-SEP-17 6B31 TITLE STRUCTURE OF RORGT IN COMPLEX WITH A NOVEL INVERSE AGONIST 2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEAR RECEPTOR ROR-GAMMA; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: NUCLEAR RECEPTOR RZR-GAMMA,NUCLEAR RECEPTOR SUBFAMILY 1 COMPND 5 GROUP F MEMBER 3,RAR-RELATED ORPHAN RECEPTOR C,RETINOID-RELATED COMPND 6 ORPHAN RECEPTOR-GAMMA; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: RORC, NR1F3, RORG, RZRG; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS COMPLEX, INVERSE AGONIST, NUCLEAR HORMONE RECEPTOR, SIGNALING KEYWDS 2 PROTEIN, SIGNALING PROTEIN-AGONIST COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR R.J.SKENE,I.HOFFMAN REVDAT 2 13-MAR-24 6B31 1 REMARK REVDAT 1 01-AUG-18 6B31 0 JRNL AUTH Y.FUKASE,A.SATO,Y.TOMATA,A.OCHIDA,M.KONO,K.YONEMORI,K.KOGA, JRNL AUTH 2 T.OKUI,M.YAMASAKI,Y.FUJITANI,H.NAKAGAWA,R.KOYAMA,M.NAKAYAMA, JRNL AUTH 3 R.SKENE,B.C.SANG,I.HOFFMAN,J.SHIRAI,S.YAMAMOTO JRNL TITL IDENTIFICATION OF NOVEL QUINAZOLINEDIONE DERIVATIVES AS ROR JRNL TITL 2 GAMMA T INVERSE AGONIST. JRNL REF BIOORG. MED. CHEM. V. 26 721 2018 JRNL REFN ESSN 1464-3391 JRNL PMID 29342416 JRNL DOI 10.1016/J.BMC.2017.12.039 REMARK 2 REMARK 2 RESOLUTION. 3.18 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.18 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 11056 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.165 REMARK 3 R VALUE (WORKING SET) : 0.161 REMARK 3 FREE R VALUE : 0.245 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 555 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3722 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 70 REMARK 3 SOLVENT ATOMS : 15 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 96.73 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.72000 REMARK 3 B22 (A**2) : 1.72000 REMARK 3 B33 (A**2) : -5.58000 REMARK 3 B12 (A**2) : 0.86000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.466 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.377 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 50.277 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: U VALUES : WITH TLS ADDED REMARK 4 REMARK 4 6B31 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-SEP-17. REMARK 100 THE DEPOSITION ID IS D_1000230190. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-APR-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11664 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.180 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 4.700 REMARK 200 R MERGE (I) : 0.08500 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.18 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.23 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.70 REMARK 200 R MERGE FOR SHELL (I) : 0.65200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 62.72 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.6M SODIUM FORMATE, 3% MPD, AND 100 REMARK 280 MM HEPES (PH 7.5), VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 43.61533 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 87.23067 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 65.42300 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 109.03833 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 21.80767 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ILE B 492 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 286 -69.55 84.03 REMARK 500 CYS A 393 58.69 -164.08 REMARK 500 HIS A 429 31.55 -96.44 REMARK 500 LYS A 469 107.72 -55.91 REMARK 500 GLU A 481 0.23 -60.07 REMARK 500 PHE A 486 -64.54 -109.82 REMARK 500 LEU A 489 12.42 58.17 REMARK 500 PRO A 491 -34.36 -19.57 REMARK 500 GLN B 286 -85.70 95.84 REMARK 500 CYS B 393 70.41 -167.23 REMARK 500 PHE B 486 -82.39 -92.48 REMARK 500 GLN B 487 34.37 -82.35 REMARK 500 HIS B 488 128.28 -31.34 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CFJ A 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CFJ B 600 DBREF 6B31 A 265 492 UNP P51449 RORG_HUMAN 265 492 DBREF 6B31 B 265 492 UNP P51449 RORG_HUMAN 265 492 SEQRES 1 A 228 ALA SER LEU THR GLU ILE GLU HIS LEU VAL GLN SER VAL SEQRES 2 A 228 CYS LYS SER TYR ARG GLU THR CYS GLN LEU ARG LEU GLU SEQRES 3 A 228 ASP LEU LEU ARG GLN ARG SER ASN ILE PHE SER ARG GLU SEQRES 4 A 228 GLU VAL THR GLY TYR GLN ARG LYS SER MET TRP GLU MET SEQRES 5 A 228 TRP GLU ARG CYS ALA HIS HIS LEU THR GLU ALA ILE GLN SEQRES 6 A 228 TYR VAL VAL GLU PHE ALA LYS ARG LEU SER GLY PHE MET SEQRES 7 A 228 GLU LEU CYS GLN ASN ASP GLN ILE VAL LEU LEU LYS ALA SEQRES 8 A 228 GLY ALA MET GLU VAL VAL LEU VAL ARG MET CYS ARG ALA SEQRES 9 A 228 TYR ASN ALA ASP ASN ARG THR VAL PHE PHE GLU GLY LYS SEQRES 10 A 228 TYR GLY GLY MET GLU LEU PHE ARG ALA LEU GLY CYS SER SEQRES 11 A 228 GLU LEU ILE SER SER ILE PHE ASP PHE SER HIS SER LEU SEQRES 12 A 228 SER ALA LEU HIS PHE SER GLU ASP GLU ILE ALA LEU TYR SEQRES 13 A 228 THR ALA LEU VAL LEU ILE ASN ALA HIS ARG PRO GLY LEU SEQRES 14 A 228 GLN GLU LYS ARG LYS VAL GLU GLN LEU GLN TYR ASN LEU SEQRES 15 A 228 GLU LEU ALA PHE HIS HIS HIS LEU CYS LYS THR HIS ARG SEQRES 16 A 228 GLN SER ILE LEU ALA LYS LEU PRO PRO LYS GLY LYS LEU SEQRES 17 A 228 ARG SER LEU CYS SER GLN HIS VAL GLU ARG LEU GLN ILE SEQRES 18 A 228 PHE GLN HIS LEU HIS PRO ILE SEQRES 1 B 228 ALA SER LEU THR GLU ILE GLU HIS LEU VAL GLN SER VAL SEQRES 2 B 228 CYS LYS SER TYR ARG GLU THR CYS GLN LEU ARG LEU GLU SEQRES 3 B 228 ASP LEU LEU ARG GLN ARG SER ASN ILE PHE SER ARG GLU SEQRES 4 B 228 GLU VAL THR GLY TYR GLN ARG LYS SER MET TRP GLU MET SEQRES 5 B 228 TRP GLU ARG CYS ALA HIS HIS LEU THR GLU ALA ILE GLN SEQRES 6 B 228 TYR VAL VAL GLU PHE ALA LYS ARG LEU SER GLY PHE MET SEQRES 7 B 228 GLU LEU CYS GLN ASN ASP GLN ILE VAL LEU LEU LYS ALA SEQRES 8 B 228 GLY ALA MET GLU VAL VAL LEU VAL ARG MET CYS ARG ALA SEQRES 9 B 228 TYR ASN ALA ASP ASN ARG THR VAL PHE PHE GLU GLY LYS SEQRES 10 B 228 TYR GLY GLY MET GLU LEU PHE ARG ALA LEU GLY CYS SER SEQRES 11 B 228 GLU LEU ILE SER SER ILE PHE ASP PHE SER HIS SER LEU SEQRES 12 B 228 SER ALA LEU HIS PHE SER GLU ASP GLU ILE ALA LEU TYR SEQRES 13 B 228 THR ALA LEU VAL LEU ILE ASN ALA HIS ARG PRO GLY LEU SEQRES 14 B 228 GLN GLU LYS ARG LYS VAL GLU GLN LEU GLN TYR ASN LEU SEQRES 15 B 228 GLU LEU ALA PHE HIS HIS HIS LEU CYS LYS THR HIS ARG SEQRES 16 B 228 GLN SER ILE LEU ALA LYS LEU PRO PRO LYS GLY LYS LEU SEQRES 17 B 228 ARG SER LEU CYS SER GLN HIS VAL GLU ARG LEU GLN ILE SEQRES 18 B 228 PHE GLN HIS LEU HIS PRO ILE HET CFJ A 600 35 HET CFJ B 600 35 HETNAM CFJ (3S)-N~1~-(3-CHLORO-4-CYANOPHENYL)-N~5~-(1,3-DIETHYL-2, HETNAM 2 CFJ 4-DIOXO-1,2,3,4-TETRAHYDROQUINAZOLIN-6-YL)-3- HETNAM 3 CFJ METHYLPENTANEDIAMIDE FORMUL 3 CFJ 2(C25 H26 CL N5 O4) FORMUL 5 HOH *15(H2 O) HELIX 1 AA1 SER A 266 CYS A 285 1 20 HELIX 2 AA2 ARG A 288 GLN A 295 1 8 HELIX 3 AA3 ARG A 296 ASN A 298 5 3 HELIX 4 AA4 SER A 301 ARG A 310 1 10 HELIX 5 AA5 SER A 312 LEU A 338 1 27 HELIX 6 AA6 CYS A 345 MET A 365 1 21 HELIX 7 AA7 GLY A 384 GLY A 392 5 9 HELIX 8 AA8 CYS A 393 LEU A 410 1 18 HELIX 9 AA9 SER A 413 ILE A 426 1 14 HELIX 10 AB1 GLU A 435 THR A 457 1 23 HELIX 11 AB2 ARG A 459 LEU A 466 5 8 HELIX 12 AB3 GLY A 470 GLN A 484 1 15 HELIX 13 AB4 SER B 266 GLU B 283 1 18 HELIX 14 AB5 ARG B 288 ARG B 296 1 9 HELIX 15 AB6 SER B 301 LYS B 311 1 11 HELIX 16 AB7 SER B 312 LEU B 338 1 27 HELIX 17 AB8 CYS B 345 CYS B 366 1 22 HELIX 18 AB9 GLY B 384 GLY B 392 5 9 HELIX 19 AC1 CYS B 393 LEU B 410 1 18 HELIX 20 AC2 SER B 413 ILE B 426 1 14 HELIX 21 AC3 GLU B 435 THR B 457 1 23 HELIX 22 AC4 ARG B 459 LEU B 466 5 8 HELIX 23 AC5 GLY B 470 ARG B 482 1 13 SHEET 1 AA1 3 TYR A 369 ASN A 370 0 SHEET 2 AA1 3 THR A 375 PHE A 378 -1 O THR A 375 N ASN A 370 SHEET 3 AA1 3 LYS A 381 GLY A 383 -1 O LYS A 381 N PHE A 378 SHEET 1 AA2 3 TYR B 369 ASN B 370 0 SHEET 2 AA2 3 THR B 375 PHE B 378 -1 O THR B 375 N ASN B 370 SHEET 3 AA2 3 LYS B 381 GLY B 383 -1 O GLY B 383 N VAL B 376 SITE 1 AC1 9 CYS A 320 HIS A 323 VAL A 361 MET A 365 SITE 2 AC1 9 ALA A 368 PHE A 377 PHE A 378 HIS A 479 SITE 3 AC1 9 HOH A 702 SITE 1 AC2 9 CYS B 320 HIS B 323 VAL B 361 MET B 365 SITE 2 AC2 9 ALA B 368 PHE B 377 PHE B 378 HOH B 701 SITE 3 AC2 9 HOH B 703 CRYST1 96.428 96.428 130.846 90.00 90.00 120.00 P 61 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010370 0.005987 0.000000 0.00000 SCALE2 0.000000 0.011975 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007643 0.00000